Table 1. Structures and in vitro inhibitory potencies of compounds 38–47 against the β5i subunit of human iCP.
| ||
Compound | R | IC50 for β5i (nM) |
38 | 227 ± 32 | |
39 | 226 ± 21 | |
40 | 351 ± 4 | |
41 | 200 ± 13 | |
42 | 141 ± 6 | |
43 | 365 ± 5 | |
44 | 174 ± 5 | |
45 | 433 ± 13 | |
46 | 264 ± 3 | |
47 | 106 ± 4 |